A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancer

By Calò Valentina   Agnese Valentina   Gargano Grazia   Corsale Simona   Gregorio Valter   Cascio Sandra   Cammareri Patrizia   Bruno Loredana   Augello Claudia   Gullo Arianna   Sisto Pasqua   Badalamenti Giuseppe   Valerio Maria   Napoli Liborio   Gebbia Nicola   Bazan Viviana   Russo Antonio  

Breast Cancer Research and Treatment, Vol. 96, Iss. 1, 2006-03 ,pp. : 97-100

Springer Publishing Company

Access to resources Recommend Favorite

Can the Status of the Breast and Ovarian Cancer Susceptibility Gene 1 Product (BRCA1) Predict Response to Taxane-Based Cancer Therapy?

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 5, 2009-06 ,pp. : 543-549

Bentham Science Publishers

Access to resources Recommend Favorite

Identification and characterization of missense alterations in the BRCA1 associated RING domain (BARD1) gene in breast and ovarian cancer

By Vogiatzi Paraskevi  

The Women's Oncology Review, Vol. 5, Iss. 4, 2005-12 ,pp. : 213-216

Informa Healthcare

Access to resources Recommend Favorite

Reduction of BRCA1 Expression in Sporadic Ovarian Cancer

By Zheng W.   Luo F.   Lu J.J.   Baltayan A.   Press M.F.   Zhang Z.-F.   Pike M.C.  

Gynecologic Oncology, Vol. 76, Iss. 3, 2000-03 ,pp. : 294-300

Elsevier

Access to resources Recommend Favorite

Therapy-related myeloid neoplasms in epithelial ovarian cancer patients carrying BRCA1 mutation: Report of two cases

By Melichar Bohuslav   Laco Jan   Fridrichová Petra   Šimkovičč Martin   Papajík Tomáš   Foretová Lenka  

Acta Oncologica, Vol. 51, Iss. 1, 2012-01 ,pp. : 136-138

Informa Healthcare

Access to resources Recommend Favorite